Acquisition by Mead Dana G Jr of 12620 shares of PulmonxCorp subject to Rule 16b-3
LUNG Stock | USD 6.26 0.14 2.19% |
Roughly 61% of Pulmonx Corp's investor base is looking to short. The analysis of overall sentiment of trading Pulmonx Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Pulmonx Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use Pulmonx Corp stock news signals to limit their universe of possible portfolio assets.
Pulmonx |
Filed transaction by Pulmonx Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Pulmonx Corp Fundamental Analysis
We analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Pulmonx Corp is currently under evaluation in target price category among its peers.
Pulmonx Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pulmonx Corp stock to make a market-neutral strategy. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics with similar companies.
Peers
Pulmonx Corp Related Equities
TMCI | Treace Medical | 5.58 | ||||
KIDS | Orthopediatrics Corp | 2.37 | ||||
IRMD | Iradimed | 1.39 | ||||
CNMD | CONMED | 1.24 | ||||
OFIX | Orthofix Medical | 1.12 | ||||
LIVN | LivaNova PLC | 0.67 | ||||
SRDX | SurModics | 0.66 | ||||
NPCE | Neuropace | 0.50 | ||||
ELMD | Electromed | 0.38 | ||||
ITGR | Integer Holdings | 0.31 | ||||
INGN | Inogen | 0.48 | ||||
SIBN | Si Bone | 1.36 | ||||
AXGN | Axogen | 1.84 | ||||
APYX | Apyx Medical | 2.11 | ||||
RXST | Rxsight | 2.53 |
Complementary Tools for Pulmonx Stock analysis
When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |